Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has shared an announcement.
Shanghai Heartcare Medical Technology Corp. Ltd. has announced an upcoming board meeting scheduled for August 29, 2025. The meeting will address the approval of the company’s interim results for the first half of 2025 and the consideration of an interim dividend, which could impact the company’s financial strategy and shareholder returns.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai Heartcare Medical Technology Corp. Ltd. is a company based in China, specializing in medical technology. It operates within the healthcare industry, focusing on the development and provision of medical products and services.
Average Trading Volume: 171,150
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.26B
Learn more about 6609 stock on TipRanks’ Stock Analysis page.